Linepharma International Limited
08550018
Some Concerns
- No accounts filed in last 18 months (-5)
- Current liabilities exceed current assets (-10)
Details
Compliance
Last accounts
31/12/2024
small
Next accounts due
30/09/2026
Confirmation statement
Last: 30/05/2026
Due 13/06/2027
Industry
Officers
director · Since 21/06/2023
CHIEF SCIENTIFIC OFFICER
FRENCH · FRANCE · Age 54
director · Since 21/06/2023
CEO
BRITISH · ENGLAND · Age 62
Also on 2 other boards
CompanyRankvs 339+ SIC 46460 peers76
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2023
Net Worth
£15.0M
Balance sheet strength
Cash
£1.2M
Cash in the bank
Net Current Assets
£15.0M
Working capital
Current Assets
£18.4M
Current Liabilities
£3.4M
Fixed Assets
£1
Debtors
£9.5M
Profit After Tax
£2.8M
Tax at Year End
Balance Sheet
EstimatesDerived
| Year | Current Ratio |
|---|---|
| 2023 | 5.40 |
Derived from filed accounts. Not audited figures.